SEC Form D private-offering filing

Antlia Bioscience, Inc.

Name: Antlia Bioscience, Inc. - new SEC Form D private-offering filing, Encinitas, CA
Published: 2026-06-05

A new SEC Form D private-offering notice from Encinitas, CA, a $20,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Antlia Bioscience, Inc. site↗ Verified via SEC Form D

Develops novel long-acting peptide therapeutics for chronic cardiometabolic diseases using its PASylation platform.

Filed 2026-06-05Filed to raise $20,000,000First money in 2026-05-22Raised so far $6,000,000HQ (as filed) Encinitas, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified antliabio.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.